Markus Christian Gershater
Direttore Tecnico/Scientifico/R&S presso Synthace Ltd.
Profilo
Markus Christian Gershater is the founder of Synthace Ltd.
He previously worked as a Research Associate at University College London and as a Biotransformation Scientist at Novacta Biosystems Ltd.
He holds a doctorate degree from the University of Durham.
Posizioni attive di Markus Christian Gershater
| Società | Posizione | Inizio |
|---|---|---|
Synthace Ltd.
 Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Precedenti posizioni note di Markus Christian Gershater
| Società | Posizione | Fine |
|---|---|---|
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| University College London | Corporate Officer/Principal | - |
Formazione di Markus Christian Gershater
| University of Durham | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Technology Services |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Markus Christian Gershater
